Over-the-counter drug poisoning among pediatric and adolescent patients presenting to emergency departments: a nationwide analysis of the COVID-19 impact

Introduction Over-the-counter drug consumption rose markedly during the COVID-19 pandemic, raising concerns about a parallel increase in pediatric and adolescent over-the-counter drug poisoning. Whether such an increase occurred, and how it compared with prescription drug poisoning, remains unclear. Our objective is to compare over-the-counter and prescription drug poisoning patterns among patients aged 18 years or younger before, during, and after the COVID-19 pandemic. Given the rise in over-the-counter drug consumption during the pandemic, we examined whether this was reflected in pediatric and adolescent emergency department visits for drug poisoning.Methods This retrospective analysis of the Emergency Department-based Injury In-depth Surveillance system (January 2017–December 2023) included all pediatric and adolescent patients aged ≤18 years presenting with drug poisoning, across pre-pandemic (January 2017–February 2020), pandemic (March 2020–March 2022), and post-pandemic (April 2022–December 2023) periods. Monthly incidence rate ratios (IRR) were estimated using Poisson regression with monthly emergency department visits as the offset to account for unequal period lengths, refitted as negative binomial when over-dispersion was present. Interrupted time series analysis evaluated changes in over-the-counter drug poisoning trends.Results Of 5,907 drug poisoning cases, the incidence rate of OTC drug poisoning increased modestly (IRR for pandemic versus pre-pandemic 1.64, 95% CI 0.98–2.76; post-pandemic versus pre-pandemic 2.10, 95% CI 1.22–3.61), whereas prescription drug poisoning rose more steeply (IRR 2.62, 95% CI 1.56–4.37; and 3.41, 95% CI 1.99–5.86, respectively). OTC drugs accounted for 31.1% of cases, with the proportion declining from 33.6% to 29.9% and 29.3% (P = 0.004), while tranquilizer (22.7% to 37.0%) and antidepressant (7.3% to 10.0%) poisoning increasedConclusion Among pediatric and adolescent patients, OTC drug poisoning declined while prescription drug poisoning rose significantly across the three periods. The pandemic-related increase in drug poisoning reflected prescription rather than OTC drugs.

Authors

Institutions

Publication Details

Journal
Clinical Toxicology
Published
2026-07-24
DOI
https://doi.org/10.1080/15563650.2026.2703877
Primary Topic
Poisoning and overdose treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Over-the-counter drug poisoning among pediatric and adolescent patients presenting to emergency departments: a nationwide analysis of the COVID-19 impact

Sejin Heo, Kwang Yul Jung
Clinical Toxicology
Poisoning and overdose treatments
article

Over-the-counter drug poisoning among pediatric and adolescent patients presenting to emergency departments: a nationwide analysis of the COVID-19 impact

Sejin Heo, Kwang Yul Jung
article en

Abstract

Introduction Over-the-counter drug consumption rose markedly during the COVID-19 pandemic, raising concerns about a parallel increase in pediatric and adolescent over-the-counter drug poisoning. Whether such an increase occurred, and how it compared with prescription drug poisoning, remains unclear. Our objective is to compare over-the-counter and prescription drug poisoning patterns among patients aged 18 years or younger before, during, and after the COVID-19 pandemic. Given the rise in over-the-counter drug consumption during the pandemic, we examined whether this was reflected in pediatric and adolescent emergency department visits for drug poisoning.Methods This retrospective analysis of the Emergency Department-based Injury In-depth Surveillance system (January 2017–December 2023) included all pediatric and adolescent patients aged ≤18 years presenting with drug poisoning, across pre-pandemic (January 2017–February 2020), pandemic (March 2020–March 2022), and post-pandemic (April 2022–December 2023) periods. Monthly incidence rate ratios (IRR) were estimated using Poisson regression with monthly emergency department visits as the offset to account for unequal period lengths, refitted as negative binomial when over-dispersion was present. Interrupted time series analysis evaluated changes in over-the-counter drug poisoning trends.Results Of 5,907 drug poisoning cases, the incidence rate of OTC drug poisoning increased modestly (IRR for pandemic versus pre-pandemic 1.64, 95% CI 0.98–2.76; post-pandemic versus pre-pandemic 2.10, 95% CI 1.22–3.61), whereas prescription drug poisoning rose more steeply (IRR 2.62, 95% CI 1.56–4.37; and 3.41, 95% CI 1.99–5.86, respectively). OTC drugs accounted for 31.1% of cases, with the proportion declining from 33.6% to 29.9% and 29.3% (P = 0.004), while tranquilizer (22.7% to 37.0%) and antidepressant (7.3% to 10.0%) poisoning increasedConclusion Among pediatric and adolescent patients, OTC drug poisoning declined while prescription drug poisoning rose significantly across the three periods. The pandemic-related increase in drug poisoning reflected prescription rather than OTC drugs.

Clinical Toxicology
Samsung Medical Center (KR), Chung-Ang University (KR), Sungkyunkwan University (KR)
Korea Disease Control and Prevention Agency, Korea Centers for Disease Control and Prevention
Good health and well-being
Openalex Percentile: Top 6%
Poisoning and overdose treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.